Gautam Borthakur, MD

CML Specialist

location_city MD Anderson Cancer Center

19 years treating Chronic Myeloid Leukemia

Clinical Expertise

Chronic Myeloid Leukemia
Myelodysplastic Syndromes

About

His primary commitment is to bring new agents/combinations to the clinic for improving outcome in patients with these diseases. While doing this, he has taken to the clinic ideas that have emerged out of the works of translational science leaders in the department of Leukemia. He has opened more than thirty investigator-initiated or industry-sponsored clinical trials in his area of interest and has an active translational research program on autophagy and epigenetic targets, for example BRD4.